| Maternal obesity, diabetes during pregnancy and epigenetic mechanisms that influence the developmental origins of cardiometabolic disease in the offspring |
19 |
| Distinguishing reference intervals and clinical decision limits - A review by the IFCC Committee on Reference Intervals and Decision Limits |
18 |
| Telomere length measurement as a clinical biomarker of aging and disease |
17 |
| Applications of mid-infrared spectroscopy in the clinical laboratory setting |
17 |
| D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications |
15 |
| Novel biomarkers of cardiovascular disease: Applications in clinical practice |
15 |
| Novel heart failure biomarkers: why do we fail to exploit their potential? |
13 |
| HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers |
13 |
| Diagnostic criteria and contributors to Gilbert's syndrome |
13 |
| Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes |
12 |
| Deep learning for image analysis: Personalizing medicine closer to the point of care |
12 |
| Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research |
12 |
| Influence of ethnicity on population reference values for biochemical markers |
12 |
| Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome |
11 |
| Bacterial imbalance and gut pathologies: Association and contribution of E-coli in inflammatory bowel disease |
10 |
| Laboratory diagnosis of Lyme borreliosis: Current state of the art and future perspectives |
9 |
| Endogenous markers for kidney function in children: a review |
9 |
| Production of CAR T-cells by GMP-grade lentiviral vectors: Latest advances and future prospects |
9 |
| Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review |
8 |
| Optimizing cancer immunotherapy: Is it time for personalized predictive biomarkers? |
8 |
| Sample management for clinical biochemistry assays: Are serum and plasma interchangeable specimens? |
7 |
| Automation and artificial intelligence in the clinical laboratory |
7 |
| Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis |
7 |
| Clinical value of fecal calprotectin |
7 |
| Hodgkin's lymphoma and its association with EBV and HIV infection |
6 |
| Thyroglobulin measurement in the management of patients with differentiated thyroid cancer |
6 |
| Delta Checks in the clinical laboratory |
6 |
| Novel therapeutic strategies for stroke: The role of autophagy |
6 |
| Polyphenols targeting diabetes via the AMP-activated protein kinase pathway; future approach to drug discovery |
5 |
| Using transferrin saturation as a diagnostic criterion for iron deficiency: A systematic review |
5 |
| Designing and optimizing new antimicrobial peptides: all targets are not the same |
5 |
| Complex interactions between the microbiome and cancer immune therapy |
4 |
| MicroRNA profiling from dried blood samples |
3 |
| The current status of blood epigenetic biomarkers for dementia |
3 |
| HbA1c method performance: The great success story of global standardization |
3 |
| Lipoprotein(a) in clinical practice: New perspectives from basic and translational science |
3 |
| Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives |
3 |
| Novel perspectives in fetal biomarker implementation for the noninvasive prenatal testing |
3 |
| Mass spectrometry in emergency toxicology: Current state and future applications |
3 |
| Niche point-of-care endocrine testing - Reviews of intraoperative parathyroid hormone and cortisol monitoring |
2 |
| Laboratory evaluation of the IFN-gamma circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease |
2 |
| Non-antibiotic therapy for Clostridioides difficile infection: A review |
2 |
| Implementation of point-of-care testing in a pediatric healthcare setting |
2 |
| Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells - is a new era coming? |
2 |
| Next-generation sequencing for the clinical management of hepatitis C virus infections: Does one test fits all purposes? |
2 |
| Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives |
2 |
| Post-translational modifications of proteins in antiphospholipid antibody syndrome |
2 |
| Benefits and risks of standardization, harmonization and conformity to opinion in clinical laboratories |
2 |
| Biochemical markers of time since death in cerebrospinal fluid: a first step towards Forensomics |
2 |
| Androgen receptor: A promising therapeutic target in breast cancer |
2 |
